Specific targeting of tumor cells by lyophilisomes functionalized with antibodies

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 87, Issue 1, 2014, Pages 80-89

  Van Bracht, Etienne ^a   Stolle, Sarah ^a,c   Hafmans, Theo G ^a   Boerman, Otto C ^b   Oosterwijk, Egbert ^a   Van Kuppevelt, Toin H ^a   Daamen, Willeke F ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Albumin; Drug delivery; hKC4 antibody; Internalization; MUC1; Nano micro particles; Tumor targeting

Indexed keywords

ANTIBODY; DRUG VEHICLE; HUMANIZED KC4 ANTIBODY; LYOPHILISOME; MUCIN 1; NANOPARTICLE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; BOVINE SERUM ALBUMIN; DRUG CARRIER; MONOCLONAL ANTIBODY; MUC1 PROTEIN, HUMAN; NANOCAPSULE; PROTEIN BINDING;

ARTICLE; CANCER CELL LINE; DRUG TARGETING; HUMAN; HUMAN CELL; OVARY TUMOR; TUMOR CELL; UTERINE CERVIX TUMOR; CHEMISTRY; CULTURE TECHNIQUE; DRUG FORMULATION; ENDOCYTOSIS; FLUORESCENCE MICROSCOPY; FREEZE DRYING; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY; PARTICLE SIZE; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ANTIBODIES, MONOCLONAL, HUMANIZED; ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; DRUG CARRIERS; DRUG COMPOUNDING; ENDOCYTOSIS; FREEZE DRYING; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MOLECULAR TARGETED THERAPY; MUCIN-1; NANOCAPSULES; PARTICLE SIZE; PROTEIN BINDING; SERUM ALBUMIN, BOVINE;

EID: 84901638902     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2014.01.005     Document Type: Article

References (44)

1. A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticle delivery of cancer drugs Annu. Rev. Med. 63 2012 185 198
2. J.D. Byrne, T. Betancourt, and L. Brannon-Peppas Active targeting schemes for nanoparticle systems in cancer therapeutics Adv. Drug Deliv. Rev. 60 2008 1615 1626
3. J.A. Zhang, and J. Pawelchak Effect of pH, ionic strength and oxygen burden on the chemical stability of EPC/cholesterol liposomes under accelerated conditions. Part 1: Lipid hydrolysis Eur. J. Pharm. Biopharm. 50 2000 357 364
4. F. Ahmed, and D.E. Discher Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles J. Control. Release 96 2004 37 53 (Pubitemid 38438488)
5. F. Alexis, E.M. Pridgen, R. Langer, and O.C. Farokhzad Nanoparticle technologies for cancer therapy Handb. Exp. Pharmacol. 2010 55 86
6. E. van Bracht, R. Raave, W.P. Verdurmen, R.G. Wismans, P.J. Geutjes, R.E. Brock, E. Oosterwijk, T.H. Van Kuppevelt, and W.F. Daamen Lyophilisomes as a new generation of drug delivery capsules Int. J. Pharm. 439 2012 127 135
7. W.F. Daamen, P.J. Geutjes, S.T.M. Nillesen, H.Th.B. Van Moerkerk, R. Wismans, T. Hafmans, L.P.W.J. Van den Heuvel, A.M.A. Pistorius, J.H. Veerkamp, J.C.M. Van Hest, and T.H. Van Kuppevelt Lyophilisomes: a new type of (bio)capsules Adv. Mater. 19 2007 673 677
8. F. Kratz Albumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticles J. Control. Release 132 2008 171 183
9. B. Elsadek, and F. Kratz Impact of albumin on drug delivery - new applications on the horizon J. Control. Release 157 2012 4 28
10. N. Dinauer, S. Balthasar, C. Weber, J. Kreuter, K. Langer, and H. von Briesen Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes Biomaterials 26 2005 5898 5906 (Pubitemid 40803459)
11. I. Steinhauser, B. Spankuch, K. Strebhardt, and K. Langer Trastuzumab-modified nanoparticles: optimisation of preparation and uptake in cancer cells Biomaterials 27 2006 4975 4983 (Pubitemid 43866920)
12. S.B. Feinstein, J. Cheirif, F.J. Ten Cate, P.R. Silverman, P.A. Heidenreich, C. Dick, R.M. Desir, W.F. Armstrong, M.A. Quinones, and P.M. Shah Safety and efficacy of a new transpulmonary ultrasound contrast agent: initial multicenter clinical results J. Am. Coll. Cardiol. 16 1990 316 324 (Pubitemid 20245847)
13. B. Geny, B. Mettauer, B. Muan, P. Bischoff, E. Epailly, F. Piquard, B. Eisenmann, and P. Haberey Safety and efficacy of a new transpulmonary echo contrast agent in echocardiographic studies in patients J. Am. Coll. Cardiol. 22 1993 1193 1198 (Pubitemid 23285776)
14. N.K. Ibrahim, N. Desai, S. Legha, P. Soon-Shiong, R.L. Theriault, E. Rivera, B. Esmaeli, S.E. Ring, A. Bedikian, G.N. Hortobagyi, and J.A. Ellerhorst Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel Clin. Cancer Res. 8 2002 1038 1044 (Pubitemid 34517637)
15. N.K. Ibrahim, B. Samuels, R. Page, D. Doval, K.M. Patel, S.C. Rao, M.K. Nair, P. Bhar, N. Desai, and G.N. Hortobagyi Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer J. Clin. Oncol. 23 2005 6019 6026
16. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284 (Pubitemid 30122932)
17. S. Wagner, F. Rothweiler, M.G. Anhorn, D. Sauer, I. Riemann, E.C. Weiss, A. Katsen-Globa, M. Michaelis, J. Cinatl Jr., D. Schwartz, J. Kreuter, B.H. von, and K. Langer Enhanced drug targeting by attachment of an anti alphav integrin antibody to doxorubicin loaded human serum albumin nanoparticles Biomaterials 31 2010 2388 2398
18. K. Loomis, B. Smith, Y. Feng, H. Garg, A. Yavlovich, R. Campbell-Massa, D.S. Dimitrov, R. Blumenthal, X. Xiao, and A. Puri Specific targeting to B cells by lipid-based nanoparticles conjugated with a novel CD22-ScFv Exp. Mol. Pathol. 88 2010 238 249
19. B.B. Van de, N. Devoogdt, A. D'Hollander, H.L. Gijs, K. Jans, L. Lagae, S. Muyldermans, G. Maes, and G. Borghs Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy ACS Nano 5 2011 4319 4328
20. E. Levi, D.S. Klimstra, A. Andea, O. Basturk, and N.V. Adsay MUC1 and MUC2 in pancreatic neoplasia J. Clin. Pathol. 57 2004 456 462 (Pubitemid 38621788)
21. P.K. Singh, and M.A. Hollingsworth Cell surface-associated mucins in signal transduction Trends Cell Biol. 16 2006 467 476 (Pubitemid 44293402)
22. J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 Int. J. Cancer 127 2010 2008 2893 2917
23. C. Yu, Y. Hu, J. Duan, W. Yuan, C. Wang, H. Xu, and X.D. Yang Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro PLoS ONE 6 2011 e24077
24. S.J. Gendler MUC1, the renaissance molecule J. Mammary Gland Biol. Neoplasia 6 2001 339 353
25. E. Garza-Licudine, D. Deo, S. Yu, A. Uz-Zaman, and W.B. Dunbar Portable nanoparticle quantization using a resizable nanopore instrument - the IZON qNano Conf. Proc. IEEE Eng Med. Biol. Soc. 2010 2010 5736 5739
26. M.L. Kakade, and I.E. Liener Determination of available lysine in proteins Anal. Biochem. 27 1969 273 280
27. C.K. Riener, G. Kada, and H.J. Gruber Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4′-dithiodipyridine Anal. Bioanal. Chem. 373 2002 266 276 (Pubitemid 34756941)
28. R.J. Simpson, Estimation of free thiols and disulfide bonds using Ellman's reagent, CSH Protoc. 2008 (2008) db.
29. J.D. Tario Jr., B.D. Gray, S.S. Wallace, K.A. Muirhead, B.M. Ohlsson-Wilhelm, and P.K. Wallace Novel lipophilic tracking dyes for monitoring cell proliferation Immunol. Invest. 36 2007 861 885
30. P.K. Wallace, J.D. Tario Jr., J.L. Fisher, S.S. Wallace, M.S. Ernstoff, and K.A. Muirhead Tracking antigen-driven responses by flow cytometry: monitoring proliferation by dye dilution Cytometry A 73 2008 1019 1034
31. F.A. Tanious, J.M. Veal, H. Buczak, L.S. Ratmeyer, and W.D. Wilson DAPI (4′,6-diamidino-2-phenylindole) binds differently to DNA and RNA: minor-groove binding at AT sites and intercalation at AU sites Biochemistry 31 1992 3103 3112
32. T. Lammers, F. Kiessling, W.E. Hennink, and G. Storm Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress J. Control. Release 161 2012 175 187
33. M.M. Cardoso, I.N. Peca, and A.C. Roque Antibody-conjugated nanoparticles for therapeutic applications Curr. Med. Chem. 19 2012 3103 3127
34. K. Cho, X. Wang, S. Nie, Z.G. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316 (Pubitemid 351413909)
35. W.H. De Jong, and P.J. Borm Drug delivery and nanoparticles:applications and hazards Int. J. Nanomed. 3 2008 133 149
36. K. Langer, S. Balthasar, V. Vogel, N. Dinauer, B.H. von, and D. Schubert Optimization of the preparation process for human serum albumin (HSA) nanoparticles Int. J. Pharm. 257 2003 169 180 (Pubitemid 36507043)
37. A.O. Elzoghby, W.M. Samy, and N.A. Elgindy Protein-based nanocarriers as promising drug and gene delivery systems J. Control. Release 161 2012 38 49
38. M.A. Hollingsworth, and B.J. Swanson Mucins in cancer: protection and control of the cell surface Nat. Rev. Cancer 4 2004 45 60 (Pubitemid 38082153)
39. Y. Chen, S. Clark, T. Wong, Y. Chen, Y. Chen, M.S. Dennis, E. Luis, F. Zhong, S. Bheddah, H. Koeppen, A. Gogineni, S. Ross, P. Polakis, and W. Mallet Armed antibodies targeting the mucin repeats of the ovarian cancer antigen, MUC16, are highly efficacious in animal tumor models Cancer Res. 67 2007 4924 4932 (Pubitemid 46910200)
40. H. Wartlick, K. Michaelis, S. Balthasar, K. Strebhardt, J. Kreuter, and K. Langer Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells J. Drug Target. 12 2004 461 471 (Pubitemid 39562430)
41. G.J. Doherty, and H.T. McMahon Mechanisms of endocytosis Annu. Rev. Biochem. 78 2009 857 902
42. S.D. Conner, and S.L. Schmid Regulated portals of entry into the cell Nature 422 2003 37 44 (Pubitemid 36323287)
43. N. Brandhonneur, F. Chevanne, V. Vie, B. Frisch, R. Primault, M.F. Le Potier, and C.P. Le Specific and non-specific phagocytosis of ligand-grafted PLGA microspheres by macrophages Eur. J. Pharm. Sci. 36 2009 474 485
44. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896